Survival in patients with CKD 3-5 after 12 months of exercise training - a post-hoc analysis of the RENEXC trial

被引:0
|
作者
Denguir, Sara [1 ,2 ]
Hellberg, Matthias [1 ,2 ]
Almquist, Martin [2 ,3 ]
Clyne, Naomi [1 ,2 ]
机构
[1] Skane Univ Hosp, Fac Med, Dept Nephrol, Dept Clin Sci Lund, Lund, Sweden
[2] Lund Univ, Lund, Sweden
[3] Skane Univ Hosp, Fac Med, Dept Surg, Dept Clin Sci Lund, Lund, Sweden
关键词
Chronic kidney disease; Physical performance; Physical activity; Exercise training; 6-Minute walking test; Sit-To-Stand test; Handgrip test; Mortality; Survival; CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; GLOMERULAR-FILTRATION-RATE; PHYSICAL-ACTIVITY; AMBULATORY PATIENTS; SECONDARY ANALYSIS; CLINICAL-OUTCOMES; DIALYSIS PATIENTS; ASSOCIATION; HEMODIALYSIS;
D O I
10.1186/s12882-024-03915-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPhysical performance is low and physical activity declines in people with chronic kidney disease (CKD). Both factors are associated with decreased survival. Our hypothesis was that improved physical performance after 12 months of exercise training would result in better survival in patients with CKD stages 3 to 5 not on kidney replacement therapy (KRT). Our aims in this study were to investigate the survival effects of (1) baseline physical performance and (2) physical performance after 12 months of exercise training.MethodsThis is a post-hoc analysis of the RENEXC trial, a randomized controlled study comparing 12 months of strength- and balance training both in combination with aerobic training. Both groups improved physical performance with no between group differences. Patients were categorized into five groups: improved >= 5%, unchanged, deteriorated >= 5%, non-completers, missing data. Univariate and multivariate Cox regression analyses were used and adjusted for age, sex, comorbidity, time on dialysis and time with a kidney transplant.Results151 patients participated, mean age 66 +/- 14 years, 65% men, eGFR 22.5 +/- 8.2 ml/min/1.73m2, average follow-up 60 months.Multivariate analysesThe baseline 6-minute walk test (6MWT) (HR 0.996; 95% CI [0.993-0.998]) and 30-second sit-to-stand (30s-STS) (HR 0.94 CI [0.89-1.0]) were positively associated with survival. After 12 months of exercise improved handgrip strength (HGS) right (HR 2.66; 95% CI [1.07-6.59]) was associated with better survival compared with deterioration. Improvement compared with noncompletion was associated with better survival (6MWT (HR 2.88; 95% CI [1.4-5.88]), HGS right (HR 4.44; 95% CI [1.79-10.98]), functional reach (HR 3.69; 95% CI [1.82-7.48]), isometric quadriceps strength right (HR 2.86; 95% CI [1.43-5.72]), 30s-STS (HR 3.44; 95% CI [1.66-7.11]).ConclusionBaseline walking distance, muscular strength and endurance in the legs were independently associated with survival in people with CKD stages 3-5 without KRT. After completing 12 months of exercise training improved walking distance, muscular strength and endurance, and balance were positively associated with survival, compared with noncompleters. Better physical performance at baseline and the ability to complete 12 months of exercise training conferred survival benefits. There are probably several factors affecting better survival. These factors require elucidation in future studies.Trial registrationClinicalTrials.gov NCT02041156. Registration date 20,240,107.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Lactate, lactate clearance and outcome after cardiac arrest: A post-hoc analysis of the TTM-Trial
    During, J.
    Dankiewicz, J.
    Cronberg, T.
    Hassager, C.
    Hovdenes, J.
    Kjaergaard, J.
    Kuiper, M.
    Nielsen, N.
    Pellis, T.
    Stammet, P.
    Vulto, J.
    Wanscher, M.
    Wise, M.
    Aneman, A.
    Friberg, H.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2018, 62 (10) : 1436 - 1442
  • [42] The treatment and survival of elderly patients with locally advanced pancreatic cancer: A post-hoc analysis of a multicenter registry
    Brada, L. J. H.
    Walma, M. S.
    Dam, R. M. van
    Vos-Geelen, J. de
    Hingh, I. H. de
    Creemers, G. J.
    Liem, M. S.
    Mekenkamp, L. J.
    Meijer, V. E. de
    Groot, D. J. A. de
    Patijn, G. A.
    Groot, J. W. B. de
    Festen, S.
    Kerver, E. D.
    Stommel, M. W. J.
    Meijerink, M. R.
    Bosscha, K.
    Pruijt, J. F.
    Polee, M. B.
    Ropela, J. A.
    Cirkel, G. A.
    Los, M.
    Wilmink, J. W.
    Mohammad, N. Haj
    van Santvoort, H. C.
    Besselink, M. G.
    Molenaar, I. Q.
    PANCREATOLOGY, 2021, 21 (01) : 163 - 169
  • [43] Effect of atorvastatin on skeletal muscles of patients with knee osteoarthritis: Post-hoc analysis of a randomised controlled trial
    Lim, Yuan Z.
    Cicuttini, Flavia M.
    Wluka, Anita E.
    Jones, Graeme
    Hill, Catherine L.
    Forbes, Andrew B.
    Tonkin, Andrew
    Berezovskaya, Sofia
    Tan, Lynn
    Ding, Changhai
    Wang, Yuanyuan
    FRONTIERS IN MEDICINE, 2022, 9
  • [44] Neutropenia and efficacy outcomes in patients with refractory mCRC: A post-hoc analysis of the phase III SUNLIGHT trial
    Prager, G.
    Tabernero, J.
    Fakih, M.
    Ciardiello, F.
    Van Cutsem, E.
    Roby, L.
    Yao, W.
    Choucair, E.
    Taieb, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S18 - S19
  • [45] Thromboprophylaxis for patients with newly diagnosed vs. recurrent cancers: a post-hoc analysis of the avert trial
    Zhang, James
    Atalla, Marina
    Mallick, Ranjeeta
    Wells, Philip S.
    Carrier, Marc
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 51 (03) : 720 - 724
  • [46] Safety and efficacy of apixaban thromboprophylaxis in cancer patients with metastatic disease: A post-hoc analysis of the AVERT trial
    Knoll, William
    Mallick, Ranjeeta
    Wells, Philip S.
    Carrier, Marc
    THROMBOSIS RESEARCH, 2021, 197 : 13 - 15
  • [47] EFFECT OF ATORVASTATIN ON SKELETAL MUSCLES OF PATIENTS WITH KNEE OSTEOARTHRITIS: POST-HOC ANALYSIS OF A RANDOMISED CONTROLLED TRIAL
    Lim, Yuan
    Cicuttini, Flavia
    Wluka, Anita
    Jones, Graeme
    Hill, Catherine
    Forbes, Andrew
    Tonkin, Andrew
    Berezovskaya, Sofia
    Tan, Lynn
    Ding, Changhai
    Wang, Yuanyuan
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 16 - 16
  • [48] MACITENTAN TREATMENT EFFECT IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION TAKING SPIRONOLACTONE: POST-HOC ANALYSIS OF THE PHASE 3 SERAPHIN TRIAL
    Safdar, Zeenat
    Jansa, Pavel
    Mehta, Sanjay
    Pulido-Zamudio, Tomas
    Sastry, B. K.
    Sitbon, Olivier
    Souza, Rogerio
    Torbicki, Adam
    Martinez, Eliana
    Zhao, Carol
    Delcroix, Marion
    CHEST, 2021, 160 (04) : 2284A - 2286A
  • [49] Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial
    Yee, Megan K.
    Nafee, Tarek
    Daaboul, Yazan
    Korjian, Serge
    AlKhalfan, Fahad
    Kerneis, Mathieu
    Wiest, Cara
    Goldhaber, Samuel Z.
    Hernandez, Adrian F.
    Hull, Russell D.
    Cohen, Alexander T.
    Harrington, Robert A.
    Gibson, C. Michael
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 45 (01) : 1 - 8
  • [50] Lixisenatide and Renal Outcomes in Patients with Type 2 Diabetes-A Post-Hoc Analysis of the ELIXA Trial
    Muskiet, Marcel A.
    Tonneijck, Lennart
    Huang, Yao
    Liu, Minzhi
    Saremi, Aramesh
    Heerspink, Hiddo Lambers.
    Van Raalte, Daniel H.
    DIABETES, 2018, 67